Overview

3T MRI Biomarkers of Glioma Treatment Response

Status:
Terminated

Trial end date:
2016-01-01

Target enrollment:

Participant gender:

Summary

This pilot clinical trial studies advanced magnetic resonance imaging (MRI) techniques in measuring treatment response in patients with high-grade glioma. New diagnostic procedures, such as advanced MRI techniques at 3 Tesla, may be more effective than standard MRI in measuring treatment response in patients receiving treatment for high-grade gliomas.

Phase:

Early Phase 1

Details

Lead Sponsor:

Vanderbilt-Ingram Cancer Center

Collaborator:

National Cancer Institute (NCI)